Publications

Drug delivery

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

31-12-2026

Health policy (Amsterdam, Netherlands)

Coverage with evidence development programs: a scoping review on characteristics and patient access.

01-09-2026

Clinical and translational radiation oncology

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

01-09-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

01-08-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

01-08-2026

Cancer chemotherapy and pharmacology

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

06-07-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

02-07-2026

Cancer discovery

Germline CDK12 variants in aggressive prostate cancer.

02-07-2026

European journal of nuclear medicine and molecular imaging

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

01-07-2026

Pharmacological research

Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue.

01-07-2026

Transplantation and cellular therapy

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

01-07-2026

Radiology. Artificial intelligence

Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy.

01-07-2026

Nature

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

01-07-2026

Neuro-oncology advances

Cancer treatment-related cognitive impairment.

01-07-2026

Clinical and translational radiation oncology

Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.

01-07-2026

European urology open science

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

01-07-2026

European urology

European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update.

01-07-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort.

01-07-2026

Annals of surgical oncology

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

01-07-2026

The Lancet. Oncology

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

01-07-2026

Thyroid : official journal of the American Thyroid Association

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

01-07-2026

The Lancet. Oncology

Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.

01-07-2026

Health policy (Amsterdam, Netherlands)

Nationwide implementation of Watch-and-Wait in rectal cancer patients in the Netherlands: Encountered barriers and lessons learned in 20 years.

01-07-2026

Annals of surgical oncology

ASO Author Reflections: Physical Functioning in Patients with Sarcoma After Amputation: Are Current Questionnaires Fit for Purpose?

01-07-2026

The European journal of health economics : HEPAC : health economics in prevention and care

A comparative analysis of managed entry agreements in Europe: trends, reporting practices, and financial outcomes.

29-06-2026

Cell death discovery

Histidine to glutamine substitutants, a regulated process that impacts cell survival and suggests histidine shortage in cancer.

27-06-2026

Ear and hearing

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

26-06-2026

World journal of urology

Photographic assessment of urostomy characteristics after ileal conduit diversion: a feasibility study.

26-06-2026

Cell reports

GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.

25-06-2026

Journal for immunotherapy of cancer

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

25-06-2026

European journal of cancer (Oxford, England : 1990)

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

25-06-2026

Journal of medical genetics

Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care.

25-06-2026

NPJ breast cancer

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

25-06-2026

Behavioral medicine (Washington, D.C.)

Factors Associated with Healthcare Providers' Lifestyle Information Provision to Adult Patients in Oncology: A Systematic Literature Review.

24-06-2026

Nature communications

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

24-06-2026

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Stakeholder perspectives on potential open-label bias in patient-reported outcome results from cancer clinical trials: evidence from the IMPROvE project.

23-06-2026

European journal of cancer (Oxford, England : 1990)

Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol.

23-06-2026

European journal of cancer (Oxford, England : 1990)

Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy.

21-06-2026

Medical image analysis

Leveraging modality-guided pre-training for dual-prompt-driven multi-cancer PET-CT segmentation.

20-06-2026

European journal of cancer (Oxford, England : 1990)

Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials.

18-06-2026

European journal of cancer (Oxford, England : 1990)

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

18-06-2026

Journal of the National Cancer Institute

Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysis.

18-06-2026

The Lancet. Oncology

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

17-06-2026

Nature communications

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

17-06-2026

European urology

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

17-06-2026

International journal of cancer

Toward a validated European instrument to measure the socioeconomic impact of cancer.

15-06-2026

European journal of cancer (Oxford, England : 1990)

Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.

13-06-2026

Journal of the National Cancer Institute

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

12-06-2026

Nature communications

Towards robust foundation models for digital pathology.

11-06-2026

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Coverage with evidence development programs: a scoping review on characteristics and patient access.

Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR): A phase I trial.

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

Germline CDK12 variants in aggressive prostate cancer.

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue.

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy.

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Cancer treatment-related cognitive impairment.

Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update.

Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort.

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.

Nationwide implementation of Watch-and-Wait in rectal cancer patients in the Netherlands: Encountered barriers and lessons learned in 20 years.

ASO Author Reflections: Physical Functioning in Patients with Sarcoma After Amputation: Are Current Questionnaires Fit for Purpose?

A comparative analysis of managed entry agreements in Europe: trends, reporting practices, and financial outcomes.

Histidine to glutamine substitutants, a regulated process that impacts cell survival and suggests histidine shortage in cancer.

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Photographic assessment of urostomy characteristics after ileal conduit diversion: a feasibility study.

GRHL and PGR control WNT4 expression via 3D looping of conserved and species-specific enhancers.

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response.

Perspectives of adolescents and young adults with advanced cancer on complete genomic analysis in standard oncology care.

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

Factors Associated with Healthcare Providers' Lifestyle Information Provision to Adult Patients in Oncology: A Systematic Literature Review.

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

Stakeholder perspectives on potential open-label bias in patient-reported outcome results from cancer clinical trials: evidence from the IMPROvE project.

Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol.

Response and survival in unresectable in-transit metastatic melanoma according to treatment strategy.

Leveraging modality-guided pre-training for dual-prompt-driven multi-cancer PET-CT segmentation.

Prognostic value for overall survival of the EORTC QLQ-C30 Summary Score: An analysis of 5 closed EORTC trials.

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

Prognostic dynamics of pathological complete response and ctDNA clearance after neoadjuvant/perioperative immunotherapy in cancer: a reconstructed individual patient analysis.

Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study.

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study.

Toward a validated European instrument to measure the socioeconomic impact of cancer.

Chemotherapy duration and patient-reported outcomes in HER2-positive early breast cancer: Results from the TRAIN-3 study.

Temporal Trends of Subsequent Malignant Neoplasms in Childhood Cancer Survivors and the Impact of Treatment Changes: A DCCSS-LATER Study.

Towards robust foundation models for digital pathology.

This site uses cookies